How is the Vir Biotechnology Inc today?

The Vir Biotechnology Inc today is trading in the green, up by 0.86% at 4.68.

How has Vir Biotechnology Inc performed historically?

The Vir Biotechnology Inc is currently trading up 0.86% on an intraday basis in the past week the index fell -11.70%. The index has been down -52.49% in the past quarter and fell -51.90% in the past year. You can view this in the overview section.

What is Vir Biotechnology Inc Annual Revenue?

Vir Biotechnology Inc Annual Revenue rose 61.32%, in the last year to $63.71 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Vir Biotechnology Inc Annual Net Profit?

Vir Biotechnology Inc Annual Net Profit rose 15.14% in the last year to $521.96 M. Its sector's average net profit growth for the last fiscal year was -11.05%.

What is Vir Biotechnology Inc Price to Earning Ratio?

Vir Biotechnology Inc Price to Earning Ratio is -1.12, which is negative.

What is Vir Biotechnology Inc Stock Price?

Vir Biotechnology Inc Stock Price fell 51.9% and underperformed its sector by 63.88% in the past year.

What is Vir Biotechnology Inc Quarterly Revenue?

Vir Biotechnology Inc Quarterly Revenue fell 96.5% YoY to $1.79 M. Its sector's average revenue growth YoY for the quarter was 3.12%.

What is Vir Biotechnology Inc Quarterly Net profit?

Vir Biotechnology Inc Quarterly Net profit fell 85.31% YoY to $120.96 M. Its sector's average net profit growth YoY for the quarter was -213.96%.

What is Vir Biotechnology Inc Debt to Equity Ratio?

Vir Biotechnology Inc Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Vir Biotechnology Inc Return on Equity(ROE)?

Vir Biotechnology Inc Return on Equity(ROE) for the last financial year was -38.09%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Vir Biotechnology Inc Mutual Fund Holding?

Vir Biotechnology Inc Mutual Fund Holding decreased by 0.31% in the last quarter to 41.95.

What is Vir Biotechnology Inc Promoter Share Holding?

Vir Biotechnology Inc Promoter Share Holding increased by 0.03% in the most recent quarter to 3.29%.

What is Vir Biotechnology Inc Institutional Holding?

Vir Biotechnology Inc Institutional Holding increased by 2.81% in the last quarter to 68.52.

Vir Biotechnology Inc XNAS: VIR

Vir Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Name: Vir Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Vir Biotechnology Inc
Rating: 0.94283325
Author: Trendlyne DVM scores

about

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborat...

4.68 0.04 (0.86%)

New 52W Low in past week

192.1K XNAS Volume

XNAS 20 May, 2025 10:53 AM (EDT)

Board Meeting

The next board meeting for Vir Biotechnology Inc is on 29 May 2025 for the purpose of Vir Biotechnology Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

16.3 / 100

Technically Bearish

21.4 / 100

1Yr Price target upside is 536%

8 analysts

Vir Biotechnology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Vir Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborat...

New 52W Low in past week

SWOT Analysis

Vir Biotechnology Inc Live Price Chart

Vir Biotechnology Inc FAQ

How is Vir Biotechnology Inc today?

Vir Biotechnology Inc today is trading in the green, and is up by 0.86% at 4.68.

How has Vir Biotechnology Inc performed historically?

Vir Biotechnology Inc is currently trading up 0.86% on an intraday basis. In the past week the stock fell -11.70%. stock has been down -52.49% in the past quarter and fell -51.90% in the past year. You can view this in the overview section.